Skip to main content
. 2022 Nov 23;12:917054. doi: 10.3389/fonc.2022.917054

Table 1.

Patients’ baseline characteristics before and after propensity score matching.

Variables Before PSM After PSM
n No RT (%) RT (%) Refused RT (%) P n No RT RT P
Age (years)
 70-74 9742 2276 (23.4) 7136 (45.8) 330 (26.0) <0.001 4510 2255 2255 1
 75-79 7545 2321 (23.9) 4889 (31.4) 335 (26.4) 4590 2295 2295
 80-84 5305 2428 (25.0) 2569 (16.5) 308 (24.3) 4390 2195 2195
 ≥85 3994 2700 (27.8) 997 (6.4) 297 (23.4) 1952 976 976
Race
 Non-Hispanic White 21687 7915 (81.4) 12707 (81.5) 1065 (83.9) 0.015 12548 6274 6274 1
 Non-Hispanic Black 1627 611 (6.3) 957 (6.1) 59 (4.6) 932 466 466
 Hispanic (All Races) 1692 656 (6.7) 954 (6.1) 82 (6.5) 1062 531 531
 Other 1580 543 (5.6) 973 (6.2) 64 (5.0) 900 450 450
Histology
 Invasive ductal carcinoma 21483 7834 (80.6) 12608 (80.9) 1041 (82.0) <0.001 12632 6313 6313 1
 Invasive lobular carcinoma 2830 892 (9.2) 1829 (11.7) 109 (8.6) 1408 704 704
 Other 2273 999 (10.3) 1154 (7.4) 120 (9.4) 1402 701 701
Grade
 Well differentiated 10491 4117 (42.3) 5806 (37.2) 568 (44.7) <0.001 6456 3228 3228 1
 Moderately differentiated 13127 4657 (47.9) 7893 (50.6) 577 (45.4) 7532 3766 3766
 Poorly/undifferentiated 2968 951 (9.8) 1892 (12.1) 125 (9.8) 1454 727 727
Tumor stage
 T1 22238 8192 (84.2) 12974 (83.2) 1072 (84.4) 0.077 13314 6657 6657 1
 T2 4348 1533 (15.8) 2617 (16.8) 198 (15.6) 2128 1064 1064
PR status
 Negative 3021 1045 (10.7) 1830 (11.7) 146 (11.5) 0.053 1598 799 799 1
 Positve 23565 8680 (89.3) 13761 (88.3) 1124 (88.5) 13844 6922 6922
Chemotherapy
 No 25876 9576 (98.5) 15039 (96.5) 1261 (99.3) <0.001 15186 7593 7593 1
 Yes 710 149 (1.5) 552 (3.5) 9 (0.7) 256 128 128